See also this year's filing and all EDGAR filings for this company.
PDF Report 0001590750_2017_Viridian_Therapeutics_Inc_DE.pdf
Logs
Graph
Absolute values for 0001590750, Viridian Therapeutics Inc.\DE
| xvar | xval | |
|---|---|---|
| 0 | IntangibleAssets | 0 |
| 1 | AssetsNonCurrent | 0 |
| 2 | AssetsCurrent | 4,259,000 |
| 3 | PropertyPlantAndEquipment | 0 |
| 4 | remainder_Assets | 0 |
| 5 | LongTermLiabilities | 0 |
| 6 | LiabilitiesCurrent | 4,585,000 |
| 7 | remainder_Liabilities | 0 |
| 8 | LaborExpense | 0 |
| 9 | CostOfGoodsAndServicesSold | 2,548,000 |
| 10 | GeneralAndAdministrativeExpense | 7,906,000 |
| 11 | GoodwillImpairmentLoss | 0 |
| 12 | OperatingCostsAndExpenses | 0 |
| 13 | DepreciationDepletionAndAmortization | 0 |
| 14 | SellingAndMarketingExpense | 1,669,000 |
| 15 | ResearchAndDevelopmentExpense | 888,000 |
| 16 | remainder_Expenses | 3,000,000 |
| 17 | remainder_Revenues | 3,337,000 |
| 18 | remainder_NetIncome | 0 |
| 19 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 4,259,000 |
| 1 | Liabilities | 4,585,000 |
| 2 | Expenses | 16,011,000 |
| 3 | Revenues | 3,337,000 |
| 4 | StockholdersEquity | -326,000 |
| 5 | NetIncome | -12,674,000 |
| 6 | ComprehensiveNetIncome | -12,674,000 |
| 7 | BaseVar | 17,288,420 |
| 8 | EconomicCapitalRatio | -3.94 |
Edgar->Model Mapping
Feature Distribution
